Associated with increased risk of myocardial infarction, all-cause mortality, severe hypoglycemia

Intermittent energy restriction equivalent to continuous energy restriction for reducing HbA1c

Per pooled data from placebo-controlled trials and data from a head-to-head study with glimepiride

Increased odds of severe hypoglycemia with history of non-severe hypoglycemia, HbA1c <6 percent

Slight differences in risk for nocturnal hypoglycemia or weight gain exist

No treatment intensification for many patients with HbA1c threshold expected to trigger intensification

Globally, ambient PM_2.5 contributed to about 3.2 million incident cases of diabetes

Metformin alone or after insulin no help in youth with new diabetes, impaired glucose tolerance

Lower risk of incident obesity for offspring whose moms have healthy BMI, engage in physical activity

No reduced risk of hypoglycemia-linked ER visits, admissions for basal insulin analog vs. NPH insulin